Clinical Trials

NCT06184750 | RECRUITING | PHASE2
200 participants

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2024-09-27
Completion:
2028-03-31
Conditions
  • Breast Atypical Ductal Hyperplasia
  • Breast Atypical Lobular Hyperplasia
  • Breast Carcinoma
  • Breast Ductal Carcinoma In Situ
  • Breast Lobular Carcinoma In Situ
  • Estrogen Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • OTHER
  • DRUG
No Results Yet
NCT06058663 | RECRUITING | PHASE1
16 participants

Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2024-06-06
Completion:
2026-11-30
Conditions
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • Oligometastatic Intrahepatic Cholangiocarcinoma
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v8
  • Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
  • Unresectable Intrahepatic Cholangiocarcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT06015880 | RECRUITING | PHASE1
30 participants

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2024-05-20
Completion:
2027-06-30
Conditions
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • High Grade B-Cell Lymphoma
  • Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page